The influences of blood glucose and duration of fasting on myocardial glucose uptake of [f]fluoro-2-deoxy-d-glucose

Nuclear Medicine Communications

Volumn 23, Issue 10, 2002, Pages 961-965

  Ding, H J ^a   Shiau, Y C ^b   Wang, J J ^b   HO, S T ^c   Kao, A ^d  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Blood glucose; Fasting; FDG; Myocardial glucose uptake

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIET RESTRICTION; FEMALE; FILM; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HEART MUSCLE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; ADOLESCENT; CLINICAL TRIAL; HEART; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SCINTISCANNING; TIME;

ADOLESCENT; ADULT; BLOOD GLUCOSE; FASTING; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HEART; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; RADIOPHARMACEUTICALS; TIME FACTORS;

EID: 0036794668     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200210000-00005     Document Type: Article

References (15)

1. Graeber GM, Gupta NC, Murray GF. Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease. J Thorac Cardiovasc Surg 1999; 117: 719-727.
2. Lowe VJ, Fletcher JW, Gobar L, et al. Prospective investigation of PET in lung nodules. J Clin Oncol 1998; 16: 1075-1084.
3. Yamanouchi M, Yoshida K, Niwayama H, et al. Effect of the duration of fasting on myocardial fluorine-18-fluorodeoxyglucose positron emission tomography images in normal males. Jpn Circ J 1996; 60: 319-327.
4. Bing RJ. Cardiac metabolism. Physiol Rev 1965; 45: 171-213.
5. Camici P, Ferrannini E, Opie LH. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Pro Cardiovasc Dis 1989; 32: 217-238.
6. Opie LH. Fuels: carbohydrate and lipids. In: The heart, physiology and metabolism. New York: Raven Press, 1991: 208-246.
7. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; 1: 785-789.
8. Kubota K, Kubota R, Yamada S, Tada M, Takahashi T, Iwata R. Re-evaluation of myocardial uptake in hyperglycemia. J Nucl Med 1996; 37: 1713-1717.
9. Knuuti MJ, Maki M, Yki Jarvinen H, et al. The effect of insulin and FFA on myocardial glucose uptake. J Mol Cell Cardiol 1995; 27: 1359-1367.
10. Sugden MC, Holness MJ, Liu YL, Smith DM, Fryer LG, Kurszynska YT. Mechanisms regulating cardiac fuel selection in hyperthyroidism. Biochem J 1992; 286: 513-517.
11. Boene A, Megeney LA, McCarthy SC, McKermott JC, Tan MH. Epinephrine administration stimulates Glu-4 translocation but reduces glucose transport in muscle. Biochem Biophys Res Commun 1992; 187: 685-691.
12. Mooradian AD. Effect of ascorbate and dehydroascorbate on tissue uptake of glucose. Diabetes 1987; 36: 1001-1004.
13. Lozeman FJ, Challiss RA, Leighton B, Newsholme EA. Effect of dipyridamole on adenosine concentration, insulin sensitivity and glucose utilization in soleus muscle of the rat. Eur J Physiol 1987; 410: 192-197.
14. Gropler RJ, Siegel BA, Lee KJ, et al. Nonuniformity in myocardial accumulation of fluorine-18fluoro-deoxyglucose in normal fasted humans. J Nucl Med 1990; 31: 1749-1756.
15. Schwaiger M, Hicks R. Regional heterogeneity of cardiac substrate metabolism? J Nucl Med 1990; 31: 1757-1760.